Ticker
IOVACompany Name
IOVANCE BIOTHERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Inventory | Inventory to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 907.44M | $ 49.83M | 5.49% |
3/31/2025 | $ 966.74M | $ 65.55M | 6.78% |
12/31/2024 | $ 910.43M | $ 51.52M | 5.66% |
9/30/2024 | $ 991.12M | $ 38.58M | 3.89% |
6/30/2024 | $ 964.32M | $ 27.85M | 2.89% |
3/31/2024 | $ 869.83M | $ 17.62M | 2.03% |
12/31/2023 | $ 780.35M | $ 10.37M | 1.33% |
9/30/2023 | $ 852.32M | $ 9.2M | 1.08% |
6/30/2023 | $ 757.29M | $ 9.72M | 1.28% |
3/31/2023 | $ 824.77M | $ 0 | 0% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Inventory / Assets
(=) Inv. to Assets
Inv. to Assets for IOVANCE BIOTHERAPEUTICS INC is calculated as follows: Inventory [ $ 0 ] / Assets [ $ 782.29M ]
(=) Inv. to Assets [ 0% ]
Minimum
Sep 30, 2020
Maximum
Mar 31, 2025
Average
Median
filtered constituents | 4.46K |
---|---|
min | 0% |
max | 98.39% |
average | 6.08% |
median | 0% |
std | 11.11% |